No assessment of the merits of running a public awareness campaign to remove all COVID-19 signs has been made.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"} , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"} , "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-31T14:49:55.293Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Health Education"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of running a public awareness campaign to remove all COVID signs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : "http://data.parliament.uk/members/5158", "tablingMemberConstituency" : {"_value" : "Great Yarmouth"} , "tablingMemberPrinted" : [{"_value" : "Rupert Lowe"} ], "uin" : "11724"} , {"_about" : "http://data.parliament.uk/resources/1737301", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1737301/answer", "answerText" : {"_value" : "
The study abstract has been reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA), as part of its continuous post approval safety monitoring procedures for the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty). The abstract is available at the following link:<\/p>
https://catalogues.ema.europa.eu/system/files/2024-06/C4591021%20Interim%205%20Study%20Report%20Abstract%20_0.pdf<\/a><\/p> The MHRA does not consider that any regulatory action is warranted at this time and will review the final study report, when it\u2019s made available by Pfizer, as part of safety monitoring procedures.<\/p> The MHRA does not publish study reports for company studies, and further publications of results are the responsibility of Pfizer-BioNTech. The MHRA continues to closely monitor the safety of all COVID-19 vaccines and will take any regulatory action necessary should any new safety concerns be identified.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
, "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
, "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-31T12:59:08.553Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-10-28", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 October 2024 to Question 6194 on Coronavirus: Vaccination, whether the Medicines and Healthcare products Regulatory Agency has made an assessment of the potential implications for future medical decisions of the Pfizer study abstract entitled, Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine, dated 12 March 2024; and when he plans to publish the full study.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4084", "label" : {"_value" : "Biography information for Esther McVey"}
}
, "tablingMemberConstituency" : {"_value" : "Tatton"}
, "tablingMemberPrinted" : [{"_value" : "Esther McVey"}
], "uin" : "11248"}
, {"_about" : "http://data.parliament.uk/resources/1737147", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1737147/answer", "answerText" : {"_value" : " The Government knows that cancer patients are waiting too long for a diagnosis and treatment. We will get the National Health Service diagnosing cancer on time, diagnosing it earlier, and treating it faster, so that more patients survive this horrible set of diseases, and we will improve patients\u2019 experience across the system. As part of this, we are committed to bringing down waits for cancer appointments with a Fit for the Future fund, providing investment for the number of computed tomography, magnetic resonance imaging, and other tests that are needed to reduce elective and cancer waiting times, thereby saving lives.<\/p> The Government will continue to support the provision of radiotherapy machines, however, since April 2022 the responsibility for investing in new radiotherapy machines has been with local systems.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
}
, "answeringMemberConstituency" : {"_value" : "Bristol South"}
, "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
, "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-31T16:08:52.24Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-10-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Radiotherapy: Medical Equipment"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of radiotherapy treatment machines in England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/350", "label" : {"_value" : "Biography information for Sir John Hayes"}
}
, "tablingMemberConstituency" : {"_value" : "South Holland and The Deepings"}
, "tablingMemberPrinted" : [{"_value" : "Sir John Hayes"}
], "uin" : "11155"}
, {"_about" : "http://data.parliament.uk/resources/1737148", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1737148/answer", "answerText" : {"_value" : " NHS England and the integrated care boards are responsible for ensuring that the healthcare needs of local communities are met. These responsibilities include considering adequate healthcare provision, care, and wider support for local populations, including in remote and rural areas.<\/p> For those who may struggle to access treatment, the NHS Healthcare Travel Costs Scheme provides financial assistance to patients in England who do not have a medical need for transport, but who require assistance with the costs of travelling to receive certain National Health Services. The NHS Non-Emergency Patient Transport Services provide funded transport where a medical condition means that a patient would struggle to safely attend their treatment independently.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
}
, "answeringMemberConstituency" : {"_value" : "Bristol South"}
, "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
, "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-31T15:47:53.947Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-10-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Radiotherapy: Rural Areas"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will have discussions with NHS England on improving access to radiotherapy treatments for cancer patients in rural areas.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/350", "label" : {"_value" : "Biography information for Sir John Hayes"}
}
, "tablingMemberConstituency" : {"_value" : "South Holland and The Deepings"}
, "tablingMemberPrinted" : [{"_value" : "Sir John Hayes"}
], "uin" : "11156"}
, {"_about" : "http://data.parliament.uk/resources/1736889", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1736889/answer", "answerText" : {"_value" : " As set out in the Delivering a Net Zero National Health Service report, published in October 2020, the NHS is committed to reducing its environmental impact, including by increasing the reuse and recycling of medical equipment. This report is available at the following link:<\/p> https://www.england.nhs.uk/greenernhs/wp-content/uploads/sites/51/2022/07/B1728-delivering-a-net-zero-nhs-july-2022.pdf<\/a><\/p> In October 2024, the Government published the Design for Life roadmap, a new strategy to transition away from all avoidable single-use medical technology products towards a functioning circular system by 2045. This roadmap is available at the following link:<\/p> https://www.gov.uk/government/publications/design-for-life-roadmap<\/a><\/p> The programme is expected to support the NHS by improving resilience, reducing waste, delivering cost savings, and achieving the NHS commitment to be net zero by 2045. The Design for Life roadmap provides examples of where NHS organisations are already achieving cost, waste, and carbon savings through reusing, remanufacturing, and recycling medical devices and equipment, in line with their local Green Plans.<\/p> In addition, NHS England collaborates with NHS Supply Chain to increase the availability of reusable products, and supports local NHS organisations to use more reusable medical devices and products, where it is safe to do so. For example, NHS England supported the Royal Surgical Colleges to develop the evidence-based Green Theatre Checklist to encourage sustainable theatre approaches, including promoting the use of reusable or remanufactured equipment, where appropriate. Further information on the checklist is available at the following link:<\/p>